Life Sciences Law attorneys know that the due diligence process is a key aspect of virtually all major business development and financing activities, from roadshows to joint collaborations, and from private equity investments to initial public offerings. However, effective due diligence is more than just making lists of documents, filling out checklists, and uploading files to a dataroom.
Perhaps more than in any other industry, life sciences companies must be vigilant in protecting confidential and proprietary information. Life Sciences Law attorneys use the highest standards of care with client information, whether HIPAA Protected Health Information, critical intellectual property, litigation, market research, sales, product, R&D, or clinical data. However, protecting client confidential information extends beyond routine document review. It also requires discretion, based upon a continuing consideration of the client's interests, relationships, and objectives. We have the experience and the expertise to recognize and protect our client's most sensitive information.
Life Sciences Law attorneys also have extensive experience in the due diligence process, both large-scale and small, including in connection with initial public offerings, joint ventures, road shows and private equity financings. Our attorneys are familiar with many of the prevailing technologies that are used in all stages of the due diligence process, from document review platforms, to virtual data rooms and online databases. We are able to integrate our expertise in this area with the other services we provide, which allows us to give our clients seamless and effective representation in many of the most fundamental and important aspects of their most significant transactions.